This paper presents an overview of the development of drug regulation and the rationale for drug regulation. It also reviews the drug regulation situation in selected countries, examines key contributing factors to observed drug regulation weaknesses, and identifies the measures that must be taken to improve drug regulation
This review looks at the status of female genital mutilation programming, the types of behaviour change strategies being implemented, their successes and failures, what lessons have been learned, and what support and strategies are required if the goal of eliminating female genital mutilation is to be achieved. The review focuses on the African and Eastern Mediterranean regions
